Invention Grant
- Patent Title: Therapeutic agent for nervous system disease
-
Application No.: US17748553Application Date: 2022-05-19
-
Publication No.: US11679122B2Publication Date: 2023-06-20
- Inventor: Hiroyuki Tanaka , Hideki Yoshikawa , Hideki Mochizuki , Tsuyoshi Murase , Tsutomu Sasaki , Kousuke Baba , Toru Iwahashi , Mitsuru Naiki
- Applicant: OSAKA UNIVERSITY , NIPPON ZOKI PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Suita
- Assignee: OSAKA UNIVERSITY,NIPPON ZOKI PHARMACEUTICAL CO., LTD.
- Current Assignee: OSAKA UNIVERSITY,NIPPON ZOKI PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Suita; JP Osaka
- Agency: Oliff PLC
- Priority: JP 2017245133 2017.12.21 JP 2018156503 2018.08.23
- The original application number of the division: US16907913 2020.06.22
- Main IPC: A61K31/714
- IPC: A61K31/714 ; A61P25/28 ; A61K9/00

Abstract:
An object is to provide a drug which is useful in treating a nervous system disease. A drug containing vitamin B12 as an active ingredient according to the present invention has an M2 macrophage/microglia induction promoting effect, an M1 macrophage/microglia induction inhibiting effect, a nerve regeneration promoting effect, and the like and is very useful as a therapeutic agent for a nervous system disease, and particularly useful as a therapeutic agent for a central nervous system disease such as cerebral infarction, dementia, or spinal cord injury.
Public/Granted literature
- US20220273692A1 THERAPEUTIC AGENT FOR NERVOUS SYSTEM DISEASE Public/Granted day:2022-09-01
Information query